Related Experiment Video
Updated: Jul 31, 2025

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.4K
Interpregnancy Interval After Stillbirth and Adverse Perinatal Outcomes
Karen J Gibbins1, Bharti Garg, Aaron B Caughey
1Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
Obstetrics and Gynecology
|May 4, 2023
Summary
A short interpregnancy interval (IPI) after stillbirth does not increase risks for adverse pregnancy outcomes in subsequent pregnancies. This finding offers reassurance to parents wishing to conceive soon after a stillbirth.
Area of Science:
- Perinatal Medicine
- Reproductive Health
- Obstetrics
Background:
- Stillbirth is a significant adverse pregnancy outcome.
- The optimal interpregnancy interval (IPI) after stillbirth is not well-established.
- Previous studies on IPI have focused on live births, not stillbirth.
Purpose of the Study:
- To examine the association between interpregnancy interval (IPI) after stillbirth and subsequent pregnancy outcomes.
- To determine if a shorter IPI increases the risk of adverse outcomes like preterm birth, preeclampsia, or recurrent stillbirth.
Main Methods:
- Retrospective cohort study of 5,581 individuals with a preceding stillbirth.
- IPI categorized into six groups, with 18-23 months as the referent.
- Logistic regression models adjusted for maternal demographics and preceding stillbirth gestational age.
Main Results:
- Adverse perinatal outcomes were common, with 26.7% experiencing preterm birth.
- No interpregnancy interval (IPI) category was associated with an increased risk of adverse perinatal outcomes.
- The shortest IPI category (less than 3 months) did not show increased risk.
Conclusions:
- Interpregnancy intervals of any length after stillbirth were not associated with increased risk of adverse outcomes in the subsequent pregnancy.
- Findings provide reassurance for bereaved parents desiring to conceive shortly after stillbirth.
- Further research may explore specific subgroups or other potential factors influencing outcomes.
Related Concept Videos
Teratogenicity
2.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K

